E-LIB Suche - Ergebnisse für: Mailankody, Sham

1

Patterns of CRS with teclistamab in relapsed/refractory mul..:

Hamadeh, Issam S. ; Shekarkhand, Tala ; Rueda, Colin...
Blood Advances. 8 (2024) 12 - p. 3038-3044 , 2024

Link: https://doi.org/10.1182/..

2

Prevalence and impact of diabetes on survival of patients w..:

Shah, Urvi A. ; Moshier, Erin ; Derkach, Andriy...
Blood Advances. 8 (2024) 1 - p. 236-247 , 2024

Link: https://doi.org/10.1182/..

3

CD8 effector T cells enhance teclistamab response in BCMA-e..:

Firestone, Ross S. ; McAvoy, Devin ; Shekarkhand, Tala...
Blood Advances. 8 (2024) 7 - p. 1600-1611 , 2024

Link: https://doi.org/10.1182/..

4

Comparison of infectious complications with BCMA-directed t..:

Nath, Karthik ; Shekarkhand, Tala ; Nemirovsky, David...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

5

Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patie..:

Pak, Wai Lun Will ; Brumwell, Natalie A. ; Kabel, Charlene C....
Kidney Medicine. 6 (2024) 8 - p. 100856 , 2024

Link: https://doi.org/10.1016/..

6

Prognostic impact of corticosteroid and tocilizumab use fol..:

Costa, Bruno Almeida ; Flynn, Jessica ; Nishimura, Noriko...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

7

Patients' Perceptions, Experiences, and Feedback on a Pilot..:

Castro, Francesca ; Chimonas, Susan ; Adintori, Peter A...
Current Developments in Nutrition. 8 (2024) - p. 103239 , 2024

Link: https://doi.org/10.1016/..

8

Antigen escape as a shared mechanism of resistance to BCMA-..:

Firestone, Ross S. ; Socci, Nicholas D. ; Shekarkhand, Tala...
Blood. 144 (2024) 4 - p. 402-407 , 2024

Link: https://doi.org/10.1182/..

9

Unscheduled health care interactions in patients with multi..:

Howard, Anna J. ; Concepcion, Isabel ; Wang, Alice X....
Blood Advances. 8 (2024) 12 - p. 3246-3253 , 2024

Link: https://doi.org/10.1182/..

10

P-484 Successful incorporation of ePRO using PROMIS-29 into..:

Shah, Gunjan ; Lobaugh, Stephanie ; Devlin, Sean...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S306 , 2023

Link: https://doi.org/10.1016/..

11

Interventions and outcomes of patients with multiple myelom..:

Van Oekelen, Oliver ; Nath, Karthik ; Mouhieddine, Tarek H....
Blood. 141 (2023) 7 - p. 756-765 , 2023

Link: https://doi.org/10.1182/..

12

CAR T‐Cell Therapy for Multiple Myeloma: A Clinical Practic..:

Sadek, Norah Layla ; Costa, Bruno Almeida ; Nath, Karthik.
Clinical Pharmacology & Therapeutics. , 2023

Link: https://doi.org/10.1002/..

13

Extreme body mass index and survival in newly diagnosed mul..:

Shah, Urvi A. ; Whiting, Karissa ; Devlin, Sean...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

P962: COMMERCIAL TECLISTAMAB IN ANTI-BCMA THERAPY EXPOSED R..:

Firestone, Ross ; Shekarkhand, Tala ; Patel, Dhwani...
HemaSphere. 7 (2023) S3 - p. e81198bb , 2023

Link: https://doi.org/10.1097/..

15

P-039 Vitamin D deficiency and clinical outcomes with chime..:

Nishimura, Noriko ; Flynn, Jessica ; Costa, Bruno...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S55-S56 , 2023

Link: https://doi.org/10.1016/..